CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Related or Unrelated Allogeneic Hematopoietic Cell Transplantation for High-Risk Malignancies, Using a Preparative Regimen of Pentostatin (Nipent®) and Alemtuzumab (Campath®)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00698685
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:37.394394+00:00
Published At: 2011-01-12T00:00:00+00:00
Record Updated At: 2017-03-31
Results Posted At: 2011-01-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia", "Lymphoma", "Hodgkin\u0027s Disease", "Hematologic Neoplasms", "Multiple Myeloma", "Carcinoma, Renal Cell"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-03-31"
protocolSection.identificationModule.nctId: "NCT00698685"
protocolSection.identificationModule.officialTitle: "Phase II Related or Unrelated Allogeneic Hematopoietic Cell Transplantation for High-Risk Malignancies, Using a Preparative Regimen of Pentostatin (Nipent\u00ae) and Alemtuzumab (Campath\u00ae)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2011-01-12"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.